麻豆传媒

Endocrinology >

Type 2 Diabetes

News, opinions and meeting coverage in endocrinology.

Blood Pressure Drop for CKD Patients on Patiromer

Sub-analyses finds those with resistant hypertension see benefits

Fanconi Syndrome Seen With Off-Label Canagliflozin

T1D patient presented 1 week after starting drug

CKD Patients With Diabetes Have Altered Gut Bugs

Presence of certain microbes could boost inflammation

NKF: Kidney Transplant Patients Face Diabetes Risk

Meta-analysis findings may impact clinical management and follow-up

Saxagliptin, Alogliptin Linked to Heart Failure, FDA Warns

Decision comes 1 year after FDA advisory committee vote

Whey Protein Tied to Weight Loss in T2D

Glucose levels also dropped with whey versus other protein-based diets

Why Did Afrezza Flop?

Patients don't hate needles that much, docs suggest

Antidepressant Use Tied to Better Diabetes Control

May reflect improved adherence to doctors' advice

Game-Changers in Cardiology: Jardiance Heart Benefit

A diabetes drug that benefits the heart

FDA Lifts Restriction On Rosiglitazone

Agency sees no need for restrictions after easing them 2 years ago

Early Weight Loss With Saxenda Predicts More

Conversely, initial nonresponse is typically maintained

Weight-Loss Surgery a Safe Option for Mildly Obese With T2D

Patients faced a 4.2% complication rate in 30 days

T1D Patients Face Nearly Double Risk for Dementia

Findings still significant after controlling for vascular risk factors.

GI Events Do Not Explain Weight Loss With Saxenda

No difference in weight loss between patients who had nausea and vomiting with diet drug, and those who didn't.

Three Diabetes Drugs Linked to Ketoacidosis, FDA Warns

FDA targets SGLT2 inhibitors canagliflozin, dapagliflozin, and empagliflozin.

Enzyme Rise May Link GLP-1, Pancreatitis

Levels of lipase and amylase don't increase after meals in patients not taking GLP-1 drugs.

TECOS Top Line: No Increase in CV Risk with DPP-4 Inhibitor

Primary and secondary endpoints met for those on sitagliptin.

Slippery Slope: Diet Drugs No Help for Heart

In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, 麻豆传媒 and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.

Prediabetes Patients Have Fewer Gut Bugs

A change for the worse apparent in the intestinal microbiome.

Endo Apps: How to Get Useful Glucose Meter Data

There are several options for downloading and interpreting important data from diabetes patients.

Morning Break: Penis Reduction? Patient Suffering

Health news and commentary from around the Web, gathered by the 麻豆传媒 staff.

Diabetes: Is This Tattoo Worth a 1,000 Needle Pricks?

UCSD researchers report early results on a tattoo to measure blood sugar.

Onglyza OK in Renal Patients

No increase in cardiovascular events seen in renally impaired SAVOR patients.

Gut Hormone May Up Dehydration Risk in T2D

Endogenous glucagon-like peptide-1 appears to inhibit fluid intake.

New Treatments for High Potassium on the Horizon

But ultimate success is far from guaranteed.

Stent Graft Keeps Vascular Access Clear

Should change practice, study leader says.

Insulin and Insulina: Bridging the Gap

Physicians need to be aware of patients' beliefs about medicinal plants.

Aphrodisiac Aids Genetic Type 2 Diabetes

About 4% of diabetes patients may benefit from yohimbine.

Review: Telcare Glucose Meter

An easy-to-use glucose monitor uploads data to the cloud for ready access.

Metformin and TSH: Is There a Link?

Canadian study suggests raises questions about metformin use in diabetics with underlying hypothyroidism.

HypoMap: A New Way to Track Hypoglycemia

Keeping accurate tabs on hypoglycemic events is a challenge, since they often happen between clinic visits. But Joslin Diabetes Center and technology company Glooko are trying to change that.

Glucometer Control Test Underused in Diabetes

ORLANDO -- Control solution for ensuring the proper function of glucose meters didn't appear to be a priority among physicians, pharmacists, or patients, researchers reported here.

Patients Want Diabetes-Friendly Meals on the Menu

ORLANDO -- It's easy to find heart-healthy or vegetarian-friendly meals labeled on restaurant menus, but diabetes patients are often left in the dark about options best suited to them.

FDA: No Clear Sign of Harm With Olmesartan in Diabetics

The evidence linking use of the angiotensin II receptor blocker (ARB) olmesartan in patients with diabetes and increased cardiovascular risk is not conclusive, according to a completed FDA safety review.

Obesity, T2D May Alter Gut Bacteria

CHICAGO -- The portfolio of gut bacteria in patients with obesity and type 2 diabetes may look different from that of healthy people, researchers reported here.

Victoza Accused of Causing Pancreatitis

The watchdog group Public Citizen has conducted its own analysis of FDA adverse event reports and concluded that the type 2 diabetes drug liraglutide(Victoza) likely causes pancreatitis, the group said.

Small eGFR Drops May Predict Kidney Outcomes

Declines in estimated glomerular filtration rate (eGFR) smaller than those that currently attract clinical attention may help predict the risk of end-stage renal disease, researchers reported.

The Day My Brother Became a Statistic

My brother would have turned 37 today. Instead, he became a statistic in 1995.

Bed Rest in Pregnancy Raises Diabetes Risk

CHICAGO -- Women who are prescribed long-term bed rest for troubled pregnancies are at increased risk of developing gestational diabetes, researchers said here.

Hypoglycemia at Night Tied to Arrhythmias

Nocturnal hypoglycemia was a major risk factor for cardiac arrhythmias in type 2 diabetes patients who were already at an increased risk for cardiovascular events, according to British researchers.

鈥�

19